Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
The American Journal of Gastroenterology|January 1, 1989
Cigarette smoking in Crohn's diseaseM D Silverstein, B A Lashner, S B Hanauer, et al.
Digestive Diseases and Sciences|March 1, 1990
Dysplasia and cancer complicating strictures in ulcerative colitisB A Lashner, B C Turner, D G Bostwick, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2010
Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled studyS Schreiber, I C Lawrance, O Ø Thomsen, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studiesG N J Tytgat, L Van Nueten, I Van De Velde, et al.
Diseases of the Colon and Rectum|December 1, 1995
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporinP R Fleshner, F Michelassi, M Rubin, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trialS B Hanauer, W J Sandborn, C Dallaire, et al.
Current Gastroenterology Reports|September 22, 2000
Malabsorption testing: a reviewP M Ginsburg, P Janefalkar, D T Rubin, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 13, 2001
Effects of billing and documentation requirements on the quantity and quality of teaching by attending physiciansJ F McConville, D T Rubin, H Humphrey, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2014
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's diseaseD T Rubin, R Mody, K L Davis, et al.
The American Journal of Gastroenterology|November 30, 2000
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel diseaseH S Te, T D Schiano, S F Kuan, et al.
Pageof 13